# FDA Inspection 1129002 - Tulex Pharmaceuticals Inc. - August 14, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/8686b7e1-fa12-491d-8f1f-3a1c0dacac55
Source feed: FDA_Inspections

> FDA Inspection 1129002 for Tulex Pharmaceuticals Inc. on August 14, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1129002
- Company Name: Tulex Pharmaceuticals Inc.
- Inspection Date: 2020-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264812 - 2025-03-24](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/3085aa66-b7a0-4815-9e58-5d1875897b55)
- [FDA Inspection 1256966 - 2024-12-05](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/2d3edd0e-d697-42dc-b14f-1cf6ba79a099)
- [FDA Inspection 1232755 - 2024-02-29](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/f617ec30-1c21-434a-bc70-2cb48d9caabe)
- [FDA Inspection 1031819 - 2017-11-21](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/a0867f8e-3b5f-4fc5-ad03-788d5b196185)

Company: https://www.globalkeysolutions.net/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c